-
SYRE Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Spyre Therapeutics (SYRE)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 89.42 mm | 89.42 mm | 89.42 mm | 89.42 mm | 89.42 mm | 89.42 mm |
Cash burn (monthly) | (no burn) | 8.32 mm | 20.42 mm | 18.52 mm | 12.40 mm | 13.12 mm |
Cash used (since last report) | n/a | 17.23 mm | 42.31 mm | 38.37 mm | 25.69 mm | 27.18 mm |
Cash remaining | n/a | 72.19 mm | 47.11 mm | 51.06 mm | 63.73 mm | 62.24 mm |
Runway (months of cash) | n/a | 8.7 | 2.3 | 2.8 | 5.1 | 4.7 |
13F holders | Current |
---|---|
Total holders | 135 |
Opened positions | 33 |
Closed positions | 22 |
Increased positions | 63 |
Reduced positions | 20 |
13F shares | Current |
---|---|
Total value | 1.37 tn |
Total shares | 71.65 mm |
Total puts | 3.40 k |
Total calls | 6.90 k |
Total put/call ratio | 0.5 |
Largest owners | Shares | Value |
---|---|---|
FMR | 8.80 mm | $204.89 bn |
EcoR1 Capital Fund Qualified | 5.00 mm | $2.28 mm |
Fairmount Funds Management | 4.02 mm | $93.54 bn |
RTW Investments | 3.62 mm | $84.32 bn |
BlackRock | 3.40 mm | $79.14 bn |
Vanguard | 2.85 mm | $66.27 bn |
Driehaus Capital Management | 2.80 mm | $65.27 bn |
VR Adviser | 2.69 mm | $62.52 bn |
Venrock Healthcare Capital Partners III | 2.69 mm | $59.81 mm |
Braidwell | 2.58 mm | $60.03 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Jan 25 | Heidy King-Jones | Stock Option Common Stock | Grant | Acquire A | No | No | 21.66 | 95,500 | 2.07 mm | 95,500 |
15 Jan 25 | Turtle Cameron | Stock Option Common Stock | Grant | Acquire A | No | No | 21.66 | 370,000 | 8.01 mm | 370,000 |
15 Jan 25 | Scott L Burrows | Stock Option Common Stock | Grant | Acquire A | No | No | 21.66 | 95,500 | 2.07 mm | 95,500 |
15 Jan 25 | Sheldon Sloan | Stock Option Common Stock | Grant | Acquire A | No | No | 21.66 | 95,500 | 2.07 mm | 95,500 |
10 Jan 25 | Michael Thomas Henderson | Common Stock | Other | Acquire J | No | No | 0 | 105,379 | 0.00 | 105,379 |